Bleichroeder LP’s Adverum Biotechnologies ADVM Stock Holding History

Bleichroeder LP’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$1.54M	–	73
2020 Q3	$1.54M	Buy	+15,000	New	+$2.25M	0.28%	41

Other funds holding ADVM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Bleichroeder LP's ADVM Position: Q4 2020 in Review

Bleichroeder LP sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 15,000 shares — an estimated $1.54M sold.

Bleichroeder LP first reported a position in ADVM in Q3 2020 and held it in 1 quarter. The position peaked at $1.54M in Q3 2020. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

Bleichroeder LP reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
Bleichroeder LP sold 15,000 Adverum Biotechnologies shares in Q4 2020, an estimated $1.54M.
Bleichroeder LP first reported a position in Adverum Biotechnologies in Q3 2020 and held it in 1 quarter.
Bleichroeder LP's Adverum Biotechnologies position peaked at $1.54M in Q3 2020.
155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.